Laboratorios Farmaceuticos Rovi S.A. operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Laboratorios Farmaceuticos Rovi S.A. with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £144.03 million [US$175.86 million]
of which 100%
was Antibodies & Related Products),
Eczacibasi Ilac Sanayi ve T.A.S.
(1.17 billion Turkish Liras [US$302.88 million]
of which 72%
was Personal Care), and
Mph Mittelstaendische Pharma Holding AG
based in Germany
(262.89 million Euro [US$278.19 million]
During the year ended December of 2015, sales at
Laboratorios Farmaceuticos Rovi S.A. were 246.01 million Euro (US$260.33 million).
increase of 3.3%
versus 2014, when the company's sales were 238.05 million Euro.
This was the fifth consecutive year of sales increases at Laboratorios Farmaceuticos Rovi S.A.
(and since 2010, sales have increased a total of 55%).
Sales of Marketing saw an increase
2.1% in 2015, from
197.76 million Euro to 201.92 million Euro.
Not all segments of Laboratorios Farmaceuticos Rovi S.A. experienced an increase in sales in 2015:
sales of Production fell 2.5% to 115.29 million Euro.